Search research articles
Contact Us
Filters
Showing results (51-60 of 136) with videos related to
Page
of 14
Sort By:
The Journal of Urology
|
May 15, 2013
Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study
Petra Krause, Uwe Fuhr, Jörg Schnitker, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 23, 2019
Quantification of adefovir and pitavastatin in human plasma and urine by LC-MS/MS: A useful tool for drug-drug interaction studies
Oliver Scherf-Clavel, Martina Kinzig, Marc S Stoffel, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2025
A Joint Pharmacometric Model of Iohexol and Creatinine Administered through a Meat Meal to Assess GFR and Renal OCT2/MATE Activity
Zhendong Chen, Qian Dong, Charalambos Dokos, et al.
European Journal of Clinical Pharmacology
|
December 17, 2008
Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
Alexander Jetter, Martina Kinzig, Michael Rodamer, et al.
Drug Metabolism and Pharmacokinetics
|
November 30, 2015
Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler
Sebastian Frechen, Ahmed Abbas Suleiman, Ali Mohammad Nejad Sigaroudi, et al.
Pharmacogenomics
|
February 29, 2008
Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
Julia Kirchheiner, Ingolf Meineke, Uwe Fuhr, et al.
Clinical Pharmacology and Therapeutics
|
October 4, 2005
The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers
Alexander Jetter, Andreas Lazar, Edgar Schömig, et al.
European Journal of Clinical Pharmacology
|
February 18, 2011
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Natig Gassanov, Nasser Semmo, Mariam Semmo, et al.
Clinical Pharmacokinetics
|
August 22, 2021
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Muhammad Bilal, Lobna El Tabei, Sören Büsker, et al.
European Journal of Clinical Pharmacology
|
June 30, 2011
Clinical impact of fluvoxamine-mediated long QTU syndrome
Amir M Nia, Kristina M Dahlem, Natig Gassanov, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 136) with videos related to
Sort By:
Page
of 14
The Journal of Urology
|
May 15, 2013
Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study
Petra Krause, Uwe Fuhr, Jörg Schnitker, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 23, 2019
Quantification of adefovir and pitavastatin in human plasma and urine by LC-MS/MS: A useful tool for drug-drug interaction studies
Oliver Scherf-Clavel, Martina Kinzig, Marc S Stoffel, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2025
A Joint Pharmacometric Model of Iohexol and Creatinine Administered through a Meat Meal to Assess GFR and Renal OCT2/MATE Activity
Zhendong Chen, Qian Dong, Charalambos Dokos, et al.
European Journal of Clinical Pharmacology
|
December 17, 2008
Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
Alexander Jetter, Martina Kinzig, Michael Rodamer, et al.
Drug Metabolism and Pharmacokinetics
|
November 30, 2015
Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler
Sebastian Frechen, Ahmed Abbas Suleiman, Ali Mohammad Nejad Sigaroudi, et al.
Pharmacogenomics
|
February 29, 2008
Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
Julia Kirchheiner, Ingolf Meineke, Uwe Fuhr, et al.
Clinical Pharmacology and Therapeutics
|
October 4, 2005
The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers
Alexander Jetter, Andreas Lazar, Edgar Schömig, et al.
European Journal of Clinical Pharmacology
|
February 18, 2011
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Natig Gassanov, Nasser Semmo, Mariam Semmo, et al.
Clinical Pharmacokinetics
|
August 22, 2021
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Muhammad Bilal, Lobna El Tabei, Sören Büsker, et al.
European Journal of Clinical Pharmacology
|
June 30, 2011
Clinical impact of fluvoxamine-mediated long QTU syndrome
Amir M Nia, Kristina M Dahlem, Natig Gassanov, et al.
Page
of 14